You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chemotherapy free regimen

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ph+ Acute Lymphoblastic Leukemia Trial in Chicago (Inotuzumab ozogamicin,

Recruiting
  • Lymphoblastic Leukemia
  • +2 more
  • Inotuzumab ozogamicin
  • +7 more
  • Chicago, Illinois
    University of Chicago Medical Center
May 16, 2022

Chemo-induced Nausea and Vomiting, Colorectal Cancer Trial in Guangzhou (Aprepitant+Tropisetron, Dexamethasone+Tropisetron)

Completed
  • Chemotherapy-induced Nausea and Vomiting
  • Colorectal Cancer
  • Guangzhou, Guangdong, China
    Gastrointestinal Hospital, Sun Yat-sen University
Jul 24, 2021

Eribulin-Based Regimen Versus Other Chemotherpy in

Active, not recruiting
  • Breast Cancer
  • Eribulin-Based Regimen
  • +2 more
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
Jul 18, 2023

Gastric Cancer Trial in Xi'an (dietary supplement, biological, drug)

Recruiting
  • Gastric Cancer
  • Taurine
  • +4 more
  • Xi'an, Shaanxi, China
    Tang-Du Hospital
Nov 2, 2023

Colorectal Cancer, Liver Metastases, Circulating Tumor Cell Trial in GuangZhou (Colorectal cancer resection combined with liver

Recruiting
  • Colorectal Cancer
  • +3 more
  • Colorectal cancer resection combined with liver metastasis resection.
  • FOLFOX chemotherapy regimen
  • GuangZhou, Guangdong, China
    The Sixth Affiliate Hospital of Sun Yat-Sen University
Apr 14, 2023

Locally Advanced Colorectal Carcinoma Trial in Beijing (Cadonilimab, FOLFOX regimen)

Recruiting
  • Locally Advanced Colorectal Carcinoma
  • Beijing, Beijing, China
    Cancer Hospital/ National Cancer Center, Chinese Academy of Medi
Nov 23, 2023

Pain Management, Opioid Use, Prostate Cancer Trial in Winston-Salem (Oxycodone, Acetaminophen, Ketamine)

Not yet recruiting
  • Pain Management
  • +2 more
  • Winston-Salem, North Carolina
    Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Feb 2, 2023

Colorectal Cancer, Liver Metastases, Circulating Tumor Cell Trial in GuangZhou (Colorectal resection surgery., FOLFOX chemo

Recruiting
  • Colorectal Cancer
  • +3 more
  • Colorectal resection surgery.
  • +2 more
  • GuangZhou, Guangdong, China
    The Sixth Affiliate Hospital of Sun Yat-Sen University
Apr 3, 2023

Gastric Cancer, Chemo Effect, Immune Checkpoint Inhibitor Trial in Shanghai (Sintilimab, paclitaxel-albumin, oxaliplatin, 5-FU)

Recruiting
  • Gastric Cancer
  • +2 more
  • Sintilimab, paclitaxel-albumin, oxaliplatin, 5-FU
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 1, 2023

Breast Cancer Trial in Chicago (Cyclophosphamide, Methotrexate, Capecitabine)

Recruiting
  • Breast Cancer
  • Chicago, Illinois
    University of Illinois
Oct 18, 2023

Colorectal Cancer Trial in Shanghai (VIC, Bevacizumab Plus Chemotherapy)

Recruiting
  • Colorectal Cancer
  • VIC
  • Bevacizumab Plus Chemotherapy
  • Shanghai, China
    Department of General Surgery, Zhongshan Hospital, Fudan Univers
Sep 14, 2022

Gastric Cancer Trial in Xi'an (dietary supplement, biological, drug)

Recruiting
  • Gastric Cancer
  • Taurine
  • +3 more
  • Xi'an, Shaanxi, China
    Tang-Du Hospital
Nov 7, 2023

Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

Recruiting
  • Chronic Myeloid Leukemia in Myeloid Blast Crisis
  • +3 more
  • based decitabine and olverembatinib（HQP1351)chemotherapy
  • Guanzhou, China
    Department of Hematology, Nanfang Hospital, Southern Medical Uni
Dec 6, 2022

Biliary Tract Cancer Trial in Worldwide (Durvalumab, Gemcitabine monotherapy, Gemcitabine + cisplatin)

Not yet recruiting
  • Biliary Tract Cancer
  • Durvalumab
  • +7 more
  • Orange, California
  • +36 more
Mar 6, 2023

Glioblastoma, GBM Trial in Suzhou (XS005 Cell Injection, Temozolomide(TMZ))

Recruiting
  • Glioblastoma
  • GBM
  • Suzhou, Jiangsu, China
    Dushu Lake Hospital Affiliated to Soochow University
Nov 23, 2023

Unresectable Locally Advanced or Metastatic Pancreatic Cancer Trial in Shanghai (surufatinib, KN046, gemcitabine)

Not yet recruiting
  • Unresectable Locally Advanced or Metastatic Pancreatic Cancer
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Apr 16, 2023

Refractory Leukemia Trial in Shanghai (CALGE-VEN- RIC-MBF)

Recruiting
  • Refractory Leukemia
  • CALGE-VEN- RIC-MBF
  • Shanghai, Shanghai, China
  • +2 more
May 22, 2023

Newly-diagnosed PCNSL Treated WithMethotrexate and

Active, not recruiting
  • Primary Central Nervous System Lymphoma
  • Shanghai, China
    Department of Hematology, Huashan Hospital, Fudan University
Oct 30, 2023

Colorectal Cancer, Esophagus Cancer, Appendix Cancer Trial (FOX dose-escalation algorithm)

Not yet recruiting
  • Colorectal Cancer
  • +4 more
  • FOX dose-escalation algorithm
  • (no location specified)
Mar 24, 2023

Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

Recruiting
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023

Colorectal Cancer Trial in Guangzhou (FOLFOX , FOLFIRI or FOLFOXIRI regimens, FOLFOX regimen)

Not yet recruiting
  • Colorectal Cancer
  • FOLFOX , FOLFIRI or FOLFOXIRI regimens
  • FOLFOX regimen
  • Guangzhou, Guangdong, China
    Nanfang Hospital, Southern Medical University
Apr 26, 2023

Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

Recruiting
  • Metastatic Esophageal Squamous Cell Carcinoma
  • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors（Sintilimab）
  • Qingdao, Shandong, China
  • +1 more
Nov 13, 2023

Pancreatic Cancer Trial in Modena (LDR, Gem-based doublets, SBRT)

Recruiting
  • Pancreatic Cancer
  • LDR
  • +2 more
  • Modena, MO, Italy
    Azienda Ospedaliero-Universitaria Policlinico di Modena
Dec 8, 2022

Acute Lymphoblastic Leukemia Trial in Ann Arbor (Dasatinib, Ponatinib, Berlin-Frankfurt-Münster Chemotherapy)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Nov 28, 2022

Gemcitabine, Biliary Tract Cancer, Immune Checkpoint Inhibitors Trial in Hangzhou (Gemcitabine-based chemo regimen combined with

Not yet recruiting
  • Gemcitabine
  • +2 more
  • Gemcitabine-based chemotherapy regimen combined with immunocheckpoint inhibitors
  • Hangzhou, Zhejiang, China
    Hangzhou First People's Hospital
Aug 2, 2022